These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 28555841)

  • 1. Regulatory Consequences of "Brexit" for the Development of Medicinal Products.
    Jackson EL; Feldschreiber P; Breckenridge A
    Clin Pharmacol Ther; 2017 Aug; 102(2):183-184. PubMed ID: 28555841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The consequences of 'Brexit' for drug discovery and development, and the regulatory implications.
    Golding BT; Waring MJ
    Expert Opin Drug Discov; 2018 Jul; 13(7):583-585. PubMed ID: 29634365
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Brexit on UK and EU Drug Regulation and Patient Access.
    Breckenridge A; Feldschreiber P
    Clin Pharmacol Ther; 2019 Apr; 105(4):923-925. PubMed ID: 30346627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress review of the European Paediatric Regulatory Framework after six years of implementation.
    Mentzer D
    Int J Pharm; 2014 Aug; 469(2):240-3. PubMed ID: 24613178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK medicines regulation: responding to current challenges.
    Richards N; Hudson I
    Br J Clin Pharmacol; 2016 Dec; 82(6):1471-1476. PubMed ID: 27580254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence Europe 2017. London, UK - February 22-23, 2017.
    Kibble A
    Drugs Today (Barc); 2017 Mar; 53(3):203-207. PubMed ID: 28447077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The regulatory framework for complementary and alternative medicines in Europe].
    Knöss W; Stolte F; Reh K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enabling Development of Paediatric Medicines in Europe: 10 Years of the EU Paediatric Regulation.
    Tomasi PA; Egger GF; Pallidis C; Saint-Raymond A
    Paediatr Drugs; 2017 Dec; 19(6):505-513. PubMed ID: 28900869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Innovative Medicines Initiative: an engine for regulatory science.
    Goldman M; Seigneuret N; Eichler HG
    Nat Rev Drug Discov; 2015 Jan; 14(1):1-2. PubMed ID: 25503331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulatory aspects of biosimilars. Myths and facts].
    Schneider CK; Weise M
    Z Rheumatol; 2015 Oct; 74(8):695-700. PubMed ID: 26385104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overhauling oversight--European drug legislation.
    Tsang L
    Nat Biotechnol; 2005 Sep; 23(9):1050-3. PubMed ID: 16151389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals.
    Gaspar R
    Nanomedicine (Lond); 2007 Apr; 2(2):143-7. PubMed ID: 17716116
    [No Abstract]   [Full Text] [Related]  

  • 13. [Review of the development in European Legislation on the harmonisation of the laws for medicinal products].
    Lehmann B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):713-21. PubMed ID: 18584107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FDA's critical path initiative: a brief introduction.
    Coons SJ
    Clin Ther; 2009 Nov; 31(11):2572-3. PubMed ID: 20110002
    [No Abstract]   [Full Text] [Related]  

  • 15. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory structures for gene therapy medicinal products in the European Union.
    Klug B; Celis P; Carr M; Reinhardt J
    Methods Enzymol; 2012; 507():337-54. PubMed ID: 22365782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will children with cancer benefit from the new European Paediatric Medicines Regulation?
    Vassal G
    Eur J Cancer; 2009 Jun; 45(9):1535-46. PubMed ID: 19419857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TradReg 2013: regulation of herbal and traditional medicinal products--European and global strategies--international symposium.
    Cranz H; Anquez-Traxler C
    J Ethnopharmacol; 2014 Dec; 158 Pt B():495-7. PubMed ID: 25281419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raising the bar for market authorisation of new drugs.
    Naci H; Cylus J; Vandoros S; Sato A; Perampaladas K
    BMJ; 2012 Aug; 345():e4261. PubMed ID: 22872693
    [No Abstract]   [Full Text] [Related]  

  • 20. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.